← Back to all earnings calls

Serina Therapeutics, Inc. Q2 FY2024 Earnings Call

Serina Therapeutics, Inc. (SER)

Earnings Call FY2024 Q2 Call date: 2024-08-09 Concluded

Share

Quarter scorecard

Revenue

$51,000

+628.6% YoY

Diluted EPS

$0.51

+363.6% YoY

Net income

$5.20M

+544.1% YoY

Documents & deck